[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:short-bowel-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":86,"states":87},"Short Bowel Syndrome",12,8,[8,15,22,29,36,42,48,54,60,67,73,79],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT03530852","A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB",[],"RECRUITING","2026-08-26T02:17:36.611194Z","2026-07-19T19:36:05.114138Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04775706","Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects",[19],"Phase 2","2026-08-26T02:15:56.561131Z","2026-05-05T02:43:29.042537Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT06326645","Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome",[26],"Early Phase 1","2026-08-03T02:55:08.613194Z","2026-05-05T02:43:28.017981Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":34,"content_modified":35},"NCT07197944","Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS",[33],"Phase 3","2026-08-26T02:15:01.639696Z","2026-05-05T02:35:31.776570Z",{"nct_id":37,"title":38,"phases":39,"status":12,"updated_at":40,"content_modified":41},"NCT05535361","A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome",[],"2026-08-26T02:18:22.309547Z","2026-05-05T02:43:28.624594Z",{"nct_id":43,"title":44,"phases":45,"status":12,"updated_at":46,"content_modified":47},"NCT05432648","Fiber Food Introduction in Pediatric Short Bowel Syndrome",[],"2026-08-26T02:16:51.982021Z","2026-07-19T19:36:05.131325Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":52,"content_modified":53},"NCT05561647","A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.362572Z",{"nct_id":55,"title":56,"phases":57,"status":12,"updated_at":58,"content_modified":59},"NCT04629014","Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure",[],"2026-08-26T02:17:39.857430Z","2026-05-13T02:55:06.256162Z",{"nct_id":61,"title":62,"phases":63,"status":64,"updated_at":65,"content_modified":66},"NCT05635747","A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:30.351130Z","2026-06-16T05:54:08.082843Z",{"nct_id":68,"title":69,"phases":70,"status":64,"updated_at":71,"content_modified":72},"NCT06240065","Successful Fiber Food Introduction in Short Bowel Syndrome",[],"2026-08-26T02:18:27.904411Z","2026-06-16T05:54:07.720090Z",{"nct_id":74,"title":75,"phases":76,"status":64,"updated_at":77,"content_modified":78},"NCT06938542","Palliative Care Needs of Children With Rare Diseases and Their Families",[],"2026-08-26T02:18:08.005333Z","2026-06-16T05:54:07.844998Z",{"nct_id":80,"title":81,"phases":82,"status":83,"updated_at":84,"content_modified":85},"NCT07228403","Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome",[33],"ACTIVE_NOT_RECRUITING","2026-08-03T02:07:10.948296Z","2026-06-16T05:54:07.874879Z",[],[88,92,96],{"state":89,"count":90,"slug":91},"Massachusetts",6,"massachusetts",{"state":93,"count":94,"slug":95},"Ohio",4,"ohio",{"state":97,"count":98,"slug":99},"California",3,"california"]